Literature DB >> 33489559

Bilateral Hydronephrosis From Retroperitoneal Fibrosis.

Radhika Sheth1, Devin Malik2.   

Abstract

Retroperitoneal fibrosis (RPF) is a rare condition characterized by fibroinflammatory tissue infiltrating and compressing retroperitoneal structures. While mostly idiopathic (idiopathic retroperitoneal fibrosis or IRF), RPF is frequently associated with certain drugs, infections, and malignancies. It is thought to be immune-mediated because of response to steroids and RPF is commonly seen with other autoimmune diseases, especially IgG4-related disease (IgG4-RD). IRF is also a part of the chronic aortitis syndromes and the presence of aortic aneurysms is another characteristic of this disease. A 63-year old woman presented with left-sided flank pain. Computed tomography (CT) scan showed left hydronephrosis from compression of the ureter by a retroperitoneal mass. A thoracoabdominal aneurysm was also noted. A [18F]- fluorodeoxyglucose positron emission tomography (FDG-PET) scan showed hypermetabolism in the mass, with no abnormally increased activity noted elsewhere. Within four months, the mass enlarged to involve the right ureter as well, leading to right hydronephrosis. She required bilateral ureteral stents and aneurysm repair. Biopsy of the mass showed dense fibrosis with a mononuclear cell infiltrate. The histology of the aneurysm specimen showed chronic periaortic inflammation. Laboratory investigations were significant for elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), with no evidence of monoclonal gammopathy. She was referred to the rheumatology clinic to receive steroid treatment for IRFIRF commonly involves the ureters and is diagnosed on CT scans during a workup for obstructive uropathy. The treatment is high dose steroids, while in resistant cases, other immunosuppressants have been used. The presentation of a patient with IRF can commonly mimic that of urinary calculi and malignancy. While rare, IRF should not be forgotten when evaluating a patient for obstructive uropathy.
Copyright © 2020, Sheth et al.

Entities:  

Keywords:  chronic aortitis; obstructive uropathy; retroperitoneal fibrosis; steroids

Year:  2020        PMID: 33489559      PMCID: PMC7811805          DOI: 10.7759/cureus.12147

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  19 in total

1.  Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.

Authors:  Lindsey G Pelkmans; Albert-Jan L H Aarnoudse; Tadek R Hendriksz; Eric F H van Bommel
Journal:  Nephrol Dial Transplant       Date:  2012-01-23       Impact factor: 5.992

2.  Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process.

Authors:  J K ORMOND
Journal:  J Urol       Date:  1948-06       Impact factor: 7.450

3.  Treatment of idiopathic retroperitoneal fibrosis using cyclosporin.

Authors:  A Marzano; A Trapani; N Leone; G C Actis; M Rizzetto
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

4.  [18F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study.

Authors:  Archie Fernando; James Pattison; Catherine Horsfield; David D'Cruz; Gary Cook; Tim O'Brien
Journal:  Eur Urol       Date:  2016-11-18       Impact factor: 20.096

5.  Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis.

Authors:  Augusto Vaglio; Maria G Catanoso; Lucia Spaggiari; Luca Magnani; Nicolò Pipitone; Pierluigi Macchioni; Lia Pulsatelli; Maria Nicastro; Gabriella Becchi; Domenico Corradi; Annibale Versari; Luigi Boiardi; Carlo Salvarani
Journal:  Arthritis Rheum       Date:  2013-09

6.  Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.

Authors:  E F H van Bommel; I Jansen; T R Hendriksz; A L H J Aarnoudse
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

7.  Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone.

Authors:  Eric F H van Bommel; Claire Siemes; Liesbeth E Hak; Sacha J van der Veer; Tadek R Hendriksz
Journal:  Am J Kidney Dis       Date:  2007-05       Impact factor: 8.860

8.  Evidence of autoimmunity in chronic periaortitis: a prospective study.

Authors:  Augusto Vaglio; Domenico Corradi; Lucio Manenti; Stefania Ferretti; Giovanni Garini; Carlo Buzio
Journal:  Am J Med       Date:  2003-04-15       Impact factor: 4.965

9.  Chronic periaortitis.

Authors:  R N Jois; K Gaffney; T Marshall; D G I Scott
Journal:  Rheumatology (Oxford)       Date:  2004-07-20       Impact factor: 7.580

10.  Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin.

Authors:  Davide Martorana; Augusto Vaglio; Paolo Greco; Adele Zanetti; Gabriella Moroni; Carlo Salvarani; Mario Savi; Carlo Buzio; Tauro M Neri
Journal:  Arthritis Rheum       Date:  2006-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.